Cintas (CTAS)
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-10-29
$218.07+2.47%
Close 2026-10-29 · 1-day change
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-10-29
Research Workspace
Put CTAS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Diversified Support Services is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 10% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, market reaction to earnings.
View ManagementExpectations look high — the market is pricing in about 47% growth a year, above the roughly 9% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskCTAS’s case rests on steady revenue growth and higher fiscal 2027 guidance, despite a sector backdrop working against it. Revenue growth accelerated to 10.9% year over year in Q1 FY2027 from 8.9%. Q1 adjusted EPS beat consensus, while the company raised its revenue outlook. CTAS trades at 42× P/E versus a 23× peer median, near its 39× history. The market is pricing in more growth than our forecast, leaving expectations full. A 23% next-quarter miss probability and elevated valuation fragility threaten that premium. Peer multiples imply a price about 44% below where it trades. Our read remains intact; this read is provisional.
Trailing returns as of 2026-10-29. CTAS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 20 analysts currently covering CTAS (as of Oct 2026).
Based on 6 Wall Street analysts offering 12-month price targets for CTAS in the last 4 months.
Continue this research
Compare CTAS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CTAS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Diversified Support Services — fair value, gap to price, and forward P/E.
Compare the value case
Put CTAS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase annual revenue guidance for fiscal 2027
Reported record margins and higher guidance support growth objectives, though the headline alone does not verify details.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $218.07
The last 12 months of price, then the range of analyst 12-month targets from today’s $218.07.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Increase annual revenue guidance
Raises revenue and EPS guidance positively impacting growth.
Advances: Raise EPS guidance
Earnings call provides insights supporting EPS growth.
Advances: Increase annual revenue guidance
Raising outlook supports growth objectives.
Advances: Complete acquisition of UniFirst Corporation
Signals progress in UniFirst acquisition, aligning with growth objectives.
Advances: Complete acquisition of UniFirst Corporation
Insider filing indicates commitment to UniFirst acquisition.
Advances: Complete acquisition of UniFirst Corporation
UniFirst acquisition approval supports growth objective.
Cintas's acquisition enhances growth potential and market position.